Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

NP & Neurologist Migraine Experts Discuss the Role of Anti-CGRP Monoclonal Antibodies in Migraine Prevention

Program Information

Program Information

ReachMD Healthcare Image

Tune in to hear Dr Obinna Moneme and NP Ms. Emily Hosler discuss where anti-CGRP monoclonal antibodies fit into a migraine treatment plan.

  • Sponsored by

  • Overview

    With the addition of anti-CGRP monoclonal antibodies to the migraine preventive therapy landscape, we now have another option for our patients. Here to talk about this treatment class are neurologist Dr Obinna Moneme and nurse practitioner Ms. Emily Hosler. They’ll share how they use anti-CGRP monoclonal antibodies in their practice for the prevention of migraine as well as how they assess treatment efficacy and set patient expectations.

    USA-334-84675 02/21

Schedule17 Oct 2021